{
    "root": "b4fff30d-25fe-4b44-aff2-cd02cc251a1c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "VOWST",
    "value": "20250321",
    "ingredients": [
        {
            "name": "DONOR HUMAN STOOL SPORES (ETHANOL TREATED)",
            "code": "9K7X6R5BMW",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17891"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        }
    ],
    "indications": {
        "text": "vowst indicated prevent recurrence clostridioides difficile infection ( cdi ) individuals 18 years age older following antibacterial treatment recurrent cdi ( rcdi ) .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "oral . ( 2 ) prior taking first dose : complete antibacterial treatment rcdi 2 4 days initiating treatment vowst . ( 2.1 ) drink 296 ml ( 10 oz ) magnesium citrate day least 8 hours prior taking first dose vowst . , participants impaired kidney function received polyethylene glycol electrolyte solution ( 250 ml golytely , approved ) . ( 2.1 ) vowst 4 capsules taken orally daily 3 consecutive days . ( 2.2 ) take dose ( 4 capsules ) empty stomach prior first meal day . ( 2.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "vowst supplied capsules bottles child-resistant caps . bottle contains 12 white capsules imprinted `` ser109 `` . bottle supplied carton . bottles 12 capsules : ndc 71881-400-12 .",
    "adverseReactions": "none .",
    "indications_original": "VOWST is indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI).",
    "contraindications_original": "For oral administration only. ( 2 ) Prior to taking the first dose: Complete antibacterial treatment for rCDI 2 to 4 days before initiating treatment with VOWST. ( 2.1 ) Drink 296 mL (10 oz) of magnesium citrate on the day before and at least 8 hours prior to taking the first dose of VOWST. In clinical studies, participants with impaired kidney function received polyethylene glycol electrolyte solution (250 mL GoLYTELY, not approved for this use). ( 2.1 ) The dosage of VOWST is 4 capsules taken orally once daily for 3 consecutive days. ( 2.2 ) Take each dose (4 capsules) on an empty stomach prior to the first meal of the day. ( 2.2 )",
    "warningsAndPrecautions_original": "VOWST is supplied as capsules in bottles with child-resistant caps. Each bottle contains 12 white capsules imprinted with \"SER109\". Each bottle is supplied in a carton.\n                  Bottles of 12 capsules:  NDC 71881-400-12.",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "VOWST",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17891"
        }
    ]
}